PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-02-07

Date Title Company
07-Feb-2020 FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals U.S. Food and Drug Administration
07-Feb-2020 FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals U.S. Food and Drug Administration
07-Feb-2020 RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis AbbVie
07-Feb-2020 Yseop launches Augmented Analyst, the next-generation AI NLG platform revolutionizing intelligent reporting automation YSEOP
07-Feb-2020 SUNFISH Pivotal Results for Risdiplam (RG7916) Demonstrate Medically Meaningful Benefit in Broadest Age Group of Patients Studied with Type 2 and 3 Spinal Muscular Atrophy PTC Therapeutics, Inc.
07-Feb-2020 ProQR Therapeutics Teams Up with the Foundation Fighting Blindness and Blueprint Genetics to Support the My Retina Tracker® Program for People Living with Inherited Retinal Diseases ProQR Therapeutics
07-Feb-2020 LEADING LIFE SCIENCE ADVISORY FIRMS LAUNCH SYNAPTIQ HEALTH – A COLLECTIVE DELIVERING INTEGRATED MARKET RESEARCH, COMMUNICATIONS AND ACCESS SERVICES Synaptiq Health
07-Feb-2020 Marinosolv® technology successfully used in preclinical study in severe eye disease Neurotrophic keratopathy Marinomed Biotech AG
07-Feb-2020 Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that Rubraca® (rucaparib) is now available and reimbursed in France. Clovis Oncology, Inc
07-Feb-2020 CapsCanada's Empty Capsules and Supply Chain Unaffected by the Coronavirus Outbreak CapsCanada
07-Feb-2020 Mediclinic Southern Africa announces approval for the acquisition of Matlosana hospitals Mediclinic International
07-Feb-2020 Advanced Therapies Apprenticeship Community roadshow showcases value of apprenticeships for upskilling in the advanced therapies industry Cell and Gene Therapy Catapult
07-Feb-2020 Freeline presents data on AAV-based gene therapies for Haemophilia B at EAHAD Freeline
07-Feb-2020 Inceptua and Portola enter exclusive distribution agreement for Ondexxya® Inceptua
07-Feb-2020 Freeline publishes further data for FLT180a Syncona Ltd
07-Feb-2020 Valo Therapeutics Announces New Funding for Immuno-Oncology Trials Valo Therapeutics
07-Feb-2020 Almac Group launches enhanced Label Approval Solution (LAS) Almac Group
07-Feb-2020 Chi-Med Announces the Exercise of Underwriters’ Over-allotment Option for Public Offering of ADSs Chi-Med
07-Feb-2020 Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis Sanofi
07-Feb-2020 PharmaLex expands compliance service offerings PharmaLex